The new painkiller is first approved after 25 years – and there is no risk of addiction, experts say.
On Thursday, January 30th, the US Food and Drug Administration announced that she had approved a new non-Iidiid painkillers from Vertex Pharmaceuticals called Suzetrigine, which is sold under the name Loavavx.
And acts, according to one patient who took the drug during the trial period. Samantha, 50, then took a unknown painkille of pain after rhinoplasty. “I had no pain,” he tells people, adding that she felt coherent after surgery. “I was sending e -hats, making calls … I immediately did my normal life,” she says.
It was much different from the way she felt on the opioids after surgery for a carpal tunnel syndrome: “I was loopy. I was painful – like, so nausea. I would dizzy,” she says. “I didn’t feel like this in drug trial.”
She also did not experience the side effect of a prison that can follow the opioids, which she described as “only awful.”
FDA headquarters in Silver Spring, Maryland. Getty Images Zepbound Remedies for Weight Loss Authorized by FDA to Treat Apnea during sleep
The new drug is an alternative to opioids, which, even if used in the short term, can lead to addiction and sometimes overdose, according to the Mayo Clinic. In 2022, more than 81,000 people died from an overdose in connection with the opioids-drastic spikes of 49,860 in 2019.
While opioids block the receptors of pain in the brain, the FDA says that Journavx acts “aiming at the path of pain signaling that includes sodium channels in the peripheral nervous system” before these pain signals reach the brain.
FDA approves a new treatment of pancreatic metastatic cancer
Of the 80 million Americans prescribed medicines for the treatment of acute pain a year, approximately half are prescribed opioid, Vertex said in a statement. Nearly 10% of patients with acute pain with opioid “will continue to use opioids long lasting, and about 85,000 patients will develop an opioid disorder annually,” it added.
“Options besides Opioids are so desperately needed,” said Dr. Jessica Oswald, associated with a doctor in emergency medicine and San Diego and Vertex acute pain. “It could” redefine pain management. ”
“Currently, all evidence suggests that this has no potential of addiction at all,” said Dr. Richard Rosenquist, president of the company at the Pain Management Department at the Cleveland Neurological Institute. “It is not different from Tylenol or ibuprofen in terms of addiction potential.”
Never miss the story -son for a daily newsletter of people to be up to date with the best of what people can offer, from news of glorious to convincing stories of human interest.
Categories: Trends
Source: HIS Education